SCHEMBL6952074

SCHEMBL6952074

Cc1ccc(S(=O)(=O)O[C@H]2C[C@H](O)C[C@@H](C(=O)O)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.47
TSHR P16473 1/20 0.43
ALDH1A1 P00352 2/20 0.43
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 1/20 0.38
ENPP3 O14638 2/20 0.38
ENPP1 P22413 2/20 0.38
ENPP2 Q13822 2/20 0.38
STAT3 P40763 1/20 0.37
TAS2R14 Q9NYV8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6946798 1.00 CYP2D6 (0.47) CYP2D6TSHRALDH1A1CA1CA2
SCHEMBL6952239 1.00 CYP2D6 (0.47) CYP2D6TSHRALDH1A1CA1CA2
SCHEMBL22553706 0.93 CYP2D6 (0.52) CYP2D6TSHRALDH1A1CA1CA2
SCHEMBL989553 0.93 CYP2D6 (0.52) CYP2D6TSHRALDH1A1CA1CA2
SCHEMBL20203253 0.89 CYP2D6 (0.56) CYP2D6CA1CA2MEN1KMT2A
SCHEMBL11027802 0.89 CYP2D6 (0.56) CYP2D6CA1CA2MEN1KMT2A
SCHEMBL11027801 0.89 CYP2D6 (0.56) CYP2D6CA1CA2MEN1KMT2A
SCHEMBL16712215 0.87 CYP2D6 (0.55) CYP2D6CA1CA2MEN1KMT2A
SCHEMBL27154302 0.87 CYP2D6 (0.55) CYP2D6CA1CA2MEN1KMT2A
SCHEMBL6949219 0.86 RORC (0.33) CYP2D6TSHRCA1CA2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235832-B1 VITAMIN D PRESCURSORS, METHOD AND INTERMEDIATES THERAMEX (MC) 2003-11-19 EP disclosed
EP-1106618-A1 Precursors of the A-ring of vitamin D, and method and intermediates for the preparation thereof LABORATOIRE THERAMEX (MC) 2001-06-13 EP disclosed
US-6191292-B1 ENZYMATIC ESTERIFICATION OF A DIOL, E.G., METHYL-3-ACETOXY-5-HYDROXY-CYCLOHEXANECARBOXYLATE BY A LIPASE AND VINYL ALKANOATE OR AN ACID ANHYDRIDE; CYCLIZATION TO A BICYCLIC(3.1.0)HEXANE DERIVATIVE LABORATOIRE THERAMEX (MC) 2001-02-20 US disclosed